Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of topical GRT7019 for chronic pain due to knee osteoarthritis
2016-002611-18Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GRT7019 in knee osteoarthritis (OA) (4 arms), sponsored by Grünenthal GmbH. Started Apr 2017; status: completed.
02
Drugs
GRT7019
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2016-002611-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002611-18.